Eucrates Biomedical Acquisition Cor... (EUCR)


0.00 (0.00%)
Symbol EUCR
Price $10.04
Beta -0.074
Volume Avg. 0.00M
Market Cap 42.229M
Shares () -
52 Week Range 9.87-10.25
1y Target Est -
DCF Unlevered EUCR DCF ->
DCF Levered EUCR LDCF ->
ROE 6.98% Neutral
ROA 43.59% Strong Buy
Operating Margin -
Debt / Equity 0.70% Neutral
P/E 47.81 Strong Buy
P/B 10.20 Strong Buy


Consensus EPS

Upgrades & Downgrades

Mr. Parag Phoolchand Saxena MBA, MS
Financial Services
Shell Companies
NASDAQ Capital Market

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.